Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Fresenius Medical Care AG & Co KGaA ST buy DirectorDealer_Intensive

Fresenius Medical Care AG & Co KGaA ST
Start price
€66.52
08.03.19 / 50%
Target price
€73.17
04.11.21
Performance (%)
-10.46%
End price
€59.56
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €59.56. The price of Fresenius Medical Care AG & Co KGaA ST has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -10.46%. Dividends of €2.51 are taken into consideration when calculating the performance. DirectorDealer_Intensive has 50% into this prediction

Fresenius Medical Care is a leading global provider of dialysis products, services and care, particularly for patients with chronic kidney disease. It operates in over 120 countries and cares for over 345,000 patients worldwide. The company specializes in renal care, manufacturing and distributing products related to dialysis and providing clinical care as well as education and support services for patients with kidney disease. Fresenius Medical Care has been listed on the Frankfurt Stock Exchange since 1996 and on the New York Stock Exchange since 1997. Its symbol, FMCQF, represents its over-the-counter (OTC) stock symbol in the United States.

Performance without dividends (%)
Name 1w 1m 1y 3y
Fresenius Medical Care AG & Co KGaA ST -0.169% -0.169% -14.841% -43.992%
iShares Core DAX® -1.785% -1.250% 11.664% 12.714%
iShares Nasdaq 100 -2.154% 0.300% 37.531% 41.653%
iShares Nikkei 225® -4.028% -3.746% 17.142% 0.393%
iShares S&P 500 -1.969% 0.307% 25.617% 40.084%

Comments by DirectorDealer_Intensive for this prediction

In the thread Fresenius Medical Care AG & Co KGaA ST diskutieren
Prediction Buy
Perf. (%) -10.46%
Target price 73.172
Change
Ends at 04.11.21

Director's Dealing: Buy

Director's Dealing / Insider Kauf von Valle, William (Vorstand)

  • Handelstag: 05.03.19
  • Volumen: 273120 €
  • Meldender: Valle, William

sharewise.com analyzes all insider trades. Together with the University of Innsbruck we have developed a trading strategy based on intensive trading. Additional information can be found in DirectorDealer_Intensive's profile.

DirectorDealer_Intensive 
0
Report Share
08.03.19
In the thread Trading Fresenius Medical Care AG & Co KGaA ST
Prediction Buy
Perf. (%) -10.46%
Target price 73.172
Change
Ends at 04.11.21

Die von DirectorDealer_Intensive gewählte maximale Laufzeit wurde überschritten

DirectorDealer_Intensive 
0
Report Share
05.11.21